Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LASS6 |
| Upstream (Parents) |
|---|
| (<<) CDX2 → LASS6 |
| (<<) ATF5 → LASS6 |
| (<<) HHEX → LASS6 |
| (<<) EHF → LASS6 |
| (<<) KLF5 → LASS6 |
| (<<) GRHL2 → LASS6 |
| (<<) NFE2L3 → LASS6 |
| (<<) SOX9 → LASS6 |
| (<<) VDR → LASS6 |
| (<<) MYC → LASS6 |
| (<<) JUN → LASS6 |
| (<<) GTF2IRD1 → LASS6 |
| Downstream (Children) |
|---|
| LASS6 → HOXD13 (>>) |
| LASS6 → NKX2-1 (>>) |
| LASS6 → THRA (>>) |
| LASS6 → POU1F1 (>>) |
| LASS6 → SOX30 (>>) |
| LASS6 → GCM1 (>>) |
| LASS6 → REL (>>) |
| LASS6 → VAV1 (>>) |
| LASS6 → ETS2 (>>) |
| LASS6 → ARNTL2 (>>) |
| LASS6 → ZNF134 (>>) |
| LASS6 → MEIS3P1 (>>) |
